Tag: Flu
Recommendations Updated for Flu Vaccine in Children
Providers may administer whichever product is appropriate and readily available to achieve the highest possible coverage
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Oseltamivir Not Linked to Reduced Risk for Flu Hospitalization
No reduced risk seen among older patients, those at risk for hospitalization
Physical Activity Affects Flu, Pneumonia Mortality
Aerobic activity, even below recommended level, linked to lower mortality, while J-shaped pattern seen for muscle-strengthening activity
Flu-Related Hospitalization Rates Higher for Indigenous People
Across high-income nations, higher disparities seen during the pandemic
Electronic Reminders Boost Flu Vaccine Uptake in Older Adults
Letters highlighting potential cardiovascular benefits of influenza vaccination found to be particularly effective
Flu Vaccine Effective for 2022/2023 Season
Vaccine effectiveness 54 percent against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years
FDA Approves First Home Test to Detect Both Flu and COVID-19
Test will be sold without a prescription and can be used by anyone 14 years and older or by an adult on children ages 2 years and older
Flu Vaccine 36 Percent Effective Against A(H3N2) in 2021/2022
All sequenced A(H3N2) viruses belonged to genetic group 3C.2a1b subclade 2a.2, which was antigenically different from 2021-2022 vaccine component
U.S. to Release Flu Meds From National Stockpile to Ease Shortages
Decision comes as the nation suffers from an unusually early and hard flu season, with about 9,300 deaths so far
